Midwest Cardiovascular Research Foundation
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2002-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.mcrfmd.com/
Clinical Trials
6
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee (BTK) Arteries
- Conditions
- Peripheral Arterial Disease
- First Posted Date
- 2022-03-17
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Midwest Cardiovascular Research Foundation
- Target Recruit Count
- 60
- Registration Number
- NCT05284240
- Locations
- 🇺🇸
Palm Vascular Centers, Miami Beach, Florida, United States
🇺🇸Midwest Cardiovascular Research Foundation, Davenport, Iowa, United States
JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon
- Conditions
- Peripheral Vascular Disease
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Midwest Cardiovascular Research Foundation
- Target Recruit Count
- 47
- Registration Number
- NCT03206762
- Locations
- 🇺🇸
Midwest Cardiovascular Research Foundation, Davenport, Iowa, United States
JetStream Atherectomy for the Treatment of In-stent Restenosis
- Conditions
- Femoropopliteal In-stent Restenosis
- First Posted Date
- 2016-04-06
- Last Posted Date
- 2021-08-11
- Lead Sponsor
- Midwest Cardiovascular Research Foundation
- Target Recruit Count
- 60
- Registration Number
- NCT02730234
- Locations
- 🇺🇸
Eastern Colorado Healthcare System, Denver, Colorado, United States
🇺🇸Florida Hospital Heartland Medical Center, Sebring, Florida, United States
🇺🇸Advocate Health, Downers Grove, Illinois, United States
JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions
- Conditions
- RestenosisPeripheral Vascular Disease
- First Posted Date
- 2012-11-07
- Last Posted Date
- 2020-03-03
- Lead Sponsor
- Midwest Cardiovascular Research Foundation
- Target Recruit Count
- 29
- Registration Number
- NCT01722877
- Locations
- 🇺🇸
Trinity Bettendorf Medical Center, Bettendorf, Iowa, United States
🇺🇸VA Medical Center, Dallas, Texas, United States
Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention
- Conditions
- RestenosisPeripheral Arterial Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-05-15
- Last Posted Date
- 2012-05-15
- Lead Sponsor
- Midwest Cardiovascular Research Foundation
- Target Recruit Count
- 100
- Registration Number
- NCT01599078
- Locations
- 🇺🇸
Trinity Medical Center, Bettendorf, Iowa, United States
- Prev
- 1
- 2
- Next